Skip to main content

Teligent, Inc. (TLGTQ)

OTCMKTS: TLGTQ · IEX Real-Time Price · USD
0.0500 -0.0190 (-27.54%)
Oct 22, 2021 3:59 PM EDT - Market closed
Market Cap16.10M
Revenue (ttm)46.30M
Net Income (ttm)-91.57M
Shares Out93.41M
EPS (ttm)-2.10
PE Ration/a
Forward PE6.29
Dividendn/a
Ex-Dividend Daten/a
Volume3,824,433
Open0.0670
Previous Close0.0690
Day's Range0.0425 - 0.0720
52-Week Range0.3000 - 1.6000
Beta1.62
AnalystsHold
Price Target1.00 (+1,900.0%)
Est. Earnings DateNov 15, 2021

About TLGTQ

Teligent, Inc., a specialty generic pharmaceutical company, develops, manufactures, markets, and sells generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. The company offers generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms. It is also involved in contract manufacturing and development business, including the development, manufacturing, filling, and package of topical semi-solid and liquid products for branded and generic pharmaceutical cust...

IndustryPharmaceuticals
Founded1977
CEOTimothy Sawyer
Employees142
Stock ExchangeOTCMKTS
Ticker SymbolTLGTQ
Full Company Profile

Financial Performance

In 2020, Teligent's revenue was $45.31 million, a decrease of -31.24% compared to the previous year's $65.90 million. Losses were -$122.02 million, 385.7% more than in 2019.

Financial Statements

Analyst Forecast

According to one analyst, the rating for Teligent stock is "Hold" and the 12-month stock price forecast is 1.00.

Price Target
$1.00
(1,900.00% upside)
Analyst Consensus: Hold

News

Teligent to Pursue Asset Sale through Voluntary Chapter 11 Process

BUENA, N.J., Oct. 14, 2021 /PRNewswire/ -- Teligent, Inc. (Nasdaq: TLGT), a New Jersey-based specialty generic pharmaceutical company ("Teligent" or the "Company"), today announced that the Company has,...

1 week ago - PRNewsWire

Top Penny Stocks to Buy Right Now? 3 to Check Out This Month

Are these top penny stocks to watch on your list in September? The post Top Penny Stocks to Buy Right Now?

Other symbols:MICTNGD
1 month ago - PennyStocks

Scott+Scott Attorneys at Law LLP Announces a Notice of Proposed Settlement of Class Action for the Teligent, Inc. Sec...

PHILADELPHIA--(BUSINESS WIRE)--If you purchased or acquired Teligent common stock from March 7, 2017 to November 6, 2017, your rights will be affected by a settlement.

2 months ago - Business Wire

Teligent, Inc. Announces Second Quarter 2021 Earnings Report and Provides Business Update

BUENA, N.J., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based generics pharmaceutical company, today announced its financial results for the second quarter of 2021 and...

2 months ago - GlobeNewsWire

Teligent, Inc. Announces Adjournment of Annual Meeting of Stockholders

Scheduled to Reconvene on July 21, 2021 Company Urgently Encourages Stockholders to Vote

3 months ago - GlobeNewsWire

Trading Biotech Penny Stocks? Check These 3 Out

Biotech penny stocks are heating up as Covid cases decline; which small-caps are on your watchlist? The post Trading Biotech Penny Stocks?

Other symbols:JAGXSEEL
4 months ago - PennyStocks

Teligent: Q1 Earnings Insights

Shares of Teligent (NASDAQ:TLGT) rose 1.1% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 13.04% year over year to ($0.26), which may not compare ...

4 months ago - Benzinga

Teligent, Inc. Announces First Quarter 2021 Earnings Report and Provides Business Update

BUENA, N.J., May 25, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based generics pharmaceutical company, today announced its financial results for the first quarter of 2021 and p...

4 months ago - GlobeNewsWire

Teligent, Inc. to Hold Conference Call for First Quarter 2021 Financial Results on Tuesday May 25, 2020

BUENA, N.J., May 21, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jersey based generics pharmaceutical company, today announced they will hold a conferenc...

5 months ago - GlobeNewsWire

Teligent, Inc. Announces 2020 Year-End Earnings Report and Provides Business Update

BUENA, N.J., May 03, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based generics pharmaceutical company, today announced its financial results for the fourth quarter and year end...

5 months ago - GlobeNewsWire

Teligent Announces Hiring of Chief Financial Officer

BUENA, N.J., April 15, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, today announced the hiring and a...

6 months ago - GlobeNewsWire

Teligent, Inc. Announces Appointment of Carter Pate to Board of Directors

BUENA, N.J., Feb. 23, 2021 /PRNewswire/ -- Teligent, Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jersey-based specialty generic pharmaceutical company, today announced it has appointed Car...

8 months ago - PRNewsWire

Teligent, Inc. Announces Appointment of William S. Marth to Board of Directors

BUENA, N.J., Feb. 16, 2021 /PRNewswire/ -- Teligent, Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jersey-based specialty generic pharmaceutical company, today announced it has appointed ind...

8 months ago - PRNewsWire

Teligent Takes Strategic Steps to Recapitalize and Position Business for Success

BUENA, N.J., Jan. 28, 2021 /PRNewswire/ -- Teligent, Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jersey-based specialty generic pharmaceutical company, today announced a series of strategi...

8 months ago - PRNewsWire

Teligent Regains Compliance with Nasdaq Filing Requirements and Nasdaq Minimum Market Value Rule

BUENA, N.J., Jan. 22, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, previously received notice from T...

9 months ago - GlobeNewsWire

Teligent, Inc. Announces Third Quarter 2020 Results

BUENA, N.J., Dec. 31, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the third quarter end...

9 months ago - GlobeNewsWire

Teligent: 7 Things for Investors to Know About TLGT Stock

Shares of TLGT stock are soaring on Monday ahead of a special shareholder vote to address Teligent's Nasdaq compliance. The post Teligent: 7 Things for Investors to Know About TLGT Stock appeared first ...

10 months ago - InvestorPlace

Teligent, Inc. Announces Adjournment of Special Meeting of Stockholders

Scheduled to Reconvene on December 16 , 2020 Company Urgently Encourages Stockholders to Vote

10 months ago - GlobeNewsWire

TLGT LONG TERM SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Teligent, Inc. and...

LOS ANGELES--(BUSINESS WIRE)---- $TLGT #TLGT--TLGT LONG TERM SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Teligent, Inc.

1 year ago - Business Wire

Teligent Announces Completion of Series D Convertible Note Exchange

BUENA, N.J., Sept. 23, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced the closing of the i...

1 year ago - GlobeNewsWire

Teligent, Inc. (TLGT) CEO Tim Sawyer on Q2 2020 Results - Earnings Call Transcript

Teligent, Inc. (TLGT) CEO Tim Sawyer on Q2 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Teligent, Inc. Announces Second Quarter 2020 Results

BUENA, N.J., Aug. 19, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the second quarter ...

1 year ago - GlobeNewsWire

Teligent, Inc. to Hold Conference Call for Second Quarter 2020 Financial Results and Business Update on Wednesday Aug...

BUENA, N.J., Aug. 14, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced they will hold a conference call at 8:00AM ET on We...

1 year ago - GlobeNewsWire

Teligent Announces Completion of Series C Convertible Note Financing and Exchange

BUENA, N.J., July 20, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced the closing of the is...

1 year ago - GlobeNewsWire

Teligent, Inc. Announces the Appointment of John Celentano as Chairman of the Board

BUENA, N.J., July 20, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT) (“Teligent” or the “Company”), a New Jersey based specialty generic pharmaceutical company, is pleased to announce that Joh...

1 year ago - GlobeNewsWire